Experiments were carried out to examine the effect of acute inflammation, induced by intra-articular injection of 2% carrageenan, on the response of articular blood vessels in the knee joints ofrabbits to adrenoceptor agonists. The responses to noradrenaline, phenylephrine, clonidine, UK-14304, and isoprenaline were examined 24 hours after carrageenan injection and compared with those of normal animals. Antagonists specific for a, and a2 were used to identify the adrenoceptors through which the responses were mediated and to examine if carrageenan treatment altered the adrenoceptor profile of these blood vessels. The evidence suggests that in the carrageenan treated animals there is a reduction in the a, response with an associated increase in the a2 response. A decrease in the number or affinity of a, adrenoceptors is indicated by the shift to the right of the noradrenaline and phenylephrine dose/response curves, whereas an increase in a2 affinity or number is suggested by the associated leftward shift in the a2 adrenoceptor agonist curves. This change in receptor profile appears to arise as a direct result of carrageenan induced joint inflammation.
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(Ann Rheum Dis 1992; 51: 1129-1133)
The regulation of synovial blood flow is of critical importance to the maintenance of a stable intra-articular environment. Vessel calibre in numerous vascular beds has been shown to be under humoral and neural control. Although there have been few studies investigating the control of blood flow within the synovium, evidence is beginning to emerge indicating that these two factors play a part in controlling synovial blood flow. Synovial vessels in the knee joints of rabbits respond to hormonal and neural stimuli, resulting in vasoconstriction which is mediated via a adrenoceptors present on and within the vascular smooth muscle.`-3
Additionally, human and animal synovium have been shown to be richly innervated by autonomic nerve fibres and sensory nerves containing neuropeptides such as substance P and calcitonin gene related peptide,4 which are potent dilators of articular blood vessels. 5 Inflammatory diseases such as rheumatoid arthritis result in increased blood flow in the affected joint but the mechanisms responsible are poorly understood. There is evidence to suggest that there is a neurogenic component in animal models of joint inflammation.6 Depletion of the nerves innervating the superficial synovium has been shown in tissue obtained from patients with rheumatoid arthritis. 4 In addition, a reduction in the neuropeptide content of the nerve fibres in deeper tissues was also observed. These factors could affect the hyperaemia associated with joint inflammation.
Thus the presence of adrenoceptors and innervation of synovial tissue suggests that hormonal and neural factors affect the regulation of blood flow. Vasodilator and vasoconstrictor agents, either neurally released or circulating in the blood, act together to maintain a homeostatic balance which is reflected in the calibre of the vessels. In inflamed tissues, changes in nerve fibre number, the amount of neurotransmitter released, or of binding ability (affinity/receptor number) could alter this control mechanism. This study attempts to examine the adrenoceptor profile of blood vessels in the knees of rabbits during acute inflammation to assess whether changes in receptor profile or affinity occur and if this is related to the vasodilatation known to occur in joint inflammation.
Materials and methods
Acute inflammation was induced in the knee joints of albino New Zealand rabbits (either sex, 2-4 kg) using a 2% solution of carrageenan (Sigma). The rabbits were anaesthetised intramuscularly with Hypnorm (Janssen) (1 mg) and a 0-1 ml bolus of carrageenan was injected into each knee, ensuring that the needle had penetrated the knee space before injecting a portion of the solution. The needle was then withdrawn slightly before injecting the remaining solution, ensuring that carrageenan was distributed throughout the synovial space. Visual inspection of the knee during the experiment allowed this to be confirmed. The animal was then allowed to recover. Approximately 24 hours after injection the animal was killed with a blow to the skull followed by exsanguination. Immediately afterwards the posterior aspect of the knee was exposed, the muscular branches of the popliteal artery ligated, and the artery cannulated as described previously.' Before placing the preparation in the tissue chamber the capsule was flushed with saline to identify any major leakages, which were then ligated.
The tissue was then transferred to a chamber filled with Locke's solution (NaClI1 5; KCI 4 7; CaCl2 2-5; MgSO4 7H20 24-1; KH2PO4 1-2, and glucose 5-6 mmol/l). Calcium chloride was added after oxygenating the solution with 95% 02 and 5% CO2. The chamber was thermostatically maintained at 35 ±1°C and the preparation perfused at a known rate with oxygenated Locke's solution using a peristaltic pump (Gilson Miniplus, 3 0 rev/min). An indirect measurement of vessel calibre was established using a pressure transducer attached downstream from the pump (fig 1) . As the pump perfusion rate was kept constant, the pressure changes occurring with drug administration reflected the variation in the degree of constriction of the blood vessels. Subsequent changes in pressure as a result of treatment were compared with the baseline perfusion pressure (control) and expressed as the maximum percentage change. After 30 minutes, to allow the preparation to stabilise, the capsule was treated with the vasoactive agent under investigation.
The drugs were added as 01 ml bolus injections via tubing connected to the cannula; (fig 3A) . Once again, however, the dose response curve is shifted slightly to the right in the carrageenan group. In the normal group clonidine produced almost no response, whereas in the carrageenan group a distinct dose dependent vasoconstriction occurred ( fig 3B) . This difference was statistically significant (p<0 01) at all doses (n=6-12). UK-14304 treatment resulted in a constrictor response in the normal and carrageenan groups ( fig 3C) . The treated animals showed the same trend but of a slightly higher magnitude at all doses; however, this was not of the same degree as clonidine. In the two instances the response curves shifted to the left, suggesting that there is an alteration in the a2 receptor profile, either an increase in number or affinity resulting from carrageenan treatment.
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Prolonged exposure to a wide range of drugs or hormones may result in an attenuation of physiological responses. Decreased responsiveness may be accompanied by a decrease in receptor number. Decreased responsiveness without an associated decrease in receptor number may also occur, however, perhaps by some form of desensitisation or reduction in receptor number accounting for an altered response.9 10 If this is so then the opposite may also be true and thus the significantly increased constrictor effect of clonidine may be due to 3 sensitisation, upregulation, or an increase in receptor number. The significant increase in response to clonidine and the associated increased magnitude of the UK-14034 response, although not significant, supports the view that there has been some alteration in the adrenoceptor profile. This change possibly represents a reduction in the number of a1 receptors with an increase in the a2 number or affinity. The shift to the right for the noradrenaline and phenylephrine response curves and the associated sensitivity to prazosin indicates a reduction in the number of a, receptors, thereby reducing the response at the higher doses.
In conclusion, the results suggest that in the carrageenan treated animals there is a change in the receptor profile, either an alteration in the affinity or a change in the proportion of the receptors. Within 24 hours of inducing acute inflammation, a reduction in the a, adrenoceptor number occurs with an associated increase in a2, either with respect to number or affinity. In addition, the evidence points to either a sensitisation of the remaining a1 receptors to clonidine or that clonidine and UK-14304 function through different a2 subtypes, carrageenan significantly increasing the response to clonidine but not to UK-14304. If this is so, then noradrenaline and UK-14304 function through the same a2 subtype. Therefore these results infer that in inflammatory diseases a subtle change in adrenoceptor profile occurs.
These findings may be of clinical relevance as it has been shown that knee joint blood vessels in patients with rheumatoid arthritis appear to lack sympathetic vasoconstrictor 'tone'. 1 The results of this study indicate that over a relatively short period there is a shift in the adrenoceptor profile from the a, to the a2 subtype. It is possible that this represents only the early stages of a process of altered adrenoceptor expression and that with chronic joint inflammation this process could proceed further still, perhaps resulting in the expression of receptors with a lower affinity for their naturally occurring ligand, noradrenaline. Reduction of sympathetic vasoconstrictor tone in the inflamed joint could therefore contribute to the hyperaemia associated with inflammation and thereby enhance this process.
